Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
Harvard Business School
Johnson and Johnson
Express Scripts

Last Updated: November 11, 2019

DrugPatentWatch Database Preview

Allopurinol - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for allopurinol and what is the scope of patent protection?

Allopurinol is the generic ingredient in six branded drugs marketed by Accord Hlthcare, Apotex Inc, Fosun Pharma, Indoco Remedies, Ipca Labs Ltd, Mutual Pharm, Mylan, Northstar Hlthcare, Puracap Pharm, Purepac Pharm, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Unichem Labs Ltd, Vintage Pharms, Watson Labs, Zydus Pharms, Abbott, Dr Reddys La, Casper Pharma Llc, West-ward Pharms Int, Mylan Institutional, and Ironwood Pharms Inc, and is included in thirty-two NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for allopurinol. Forty-four suppliers are listed for this compound.

Drug Prices for allopurinol

See drug prices for allopurinol

Drug Sales Revenue Trends for allopurinol

See drug sales revenues for allopurinol

Recent Clinical Trials for allopurinol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesEarly Phase 1
National Institutes of Health (NIH)Early Phase 1
Instituto Nacional de RehabilitacionPhase 3

See all allopurinol clinical trials

Pharmacology for allopurinol
Medical Subject Heading (MeSH) Categories for allopurinol

US Patents and Regulatory Information for allopurinol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms ALLOPURINOL allopurinol TABLET;ORAL 075798-001 Jun 27, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
Indoco Remedies ALLOPURINOL allopurinol TABLET;ORAL 204467-002 Jul 28, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex Inc ALLOPURINOL allopurinol TABLET;ORAL 077353-002 Sep 8, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Ironwood Pharms Inc DUZALLO allopurinol; lesinurad TABLET;ORAL 209203-002 Aug 18, 2017 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Mutual Pharm ALLOPURINOL allopurinol TABLET;ORAL 070466-001 Dec 24, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Ironwood Pharms Inc DUZALLO allopurinol; lesinurad TABLET;ORAL 209203-002 Aug 18, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for allopurinol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott LOPURIN allopurinol TABLET;ORAL 018297-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Abbott LOPURIN allopurinol TABLET;ORAL 018297-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Merck
Moodys
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.